Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Hepatic hemangioendothelioma: successful treatment with steroid in a very-low-birth-weight infant. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1996 Jan-Feb;37(1):56-8

Date

01/01/1996

Pubmed ID

8936013

Scopus ID

2-s2.0-0029680371   5 Citations

Abstract

A female infant, born at the gestational age of 29 weeks with a birthweight of 1,350 gm, developed progressive hepatomegaly at 10 days of age. Congestive heart failure gradually developed, and hepatic hemangioendothelioma was diagnosed at 1 month of age by open biopsy. Due to rapid enlargement of the tumor and progressive heart failure, steroid therapy was given from 36 days of age, including methylprednisolone 15 mg/kg/day for 3 days and 10 mg/kg/day for 4 days, then prednisolone 4 mg/kg/day for 20 days followed by tapering till 74 days of age. The tumor regressed gradually and was not detectable by sonography at 33 months of age. We suggest that, even in very-low-birthweight infants, the prognosis of hepatic hemangioendothelioma may be improved with aggressive therapy when symptoms develop during tumor progression, and that steroid should be the initial treatment.

Author List

Wu TJ, Teng RJ, Tsou Yau KI

Authors

Ru-Jeng Teng MD Associate Professor in the Pediatrics department at Medical College of Wisconsin
Tzong-Jin Wu MD Associate Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Hemangioendothelioma
Humans
Infant, Newborn
Infant, Premature, Diseases
Infant, Very Low Birth Weight
Liver Neoplasms
Methylprednisolone
Prednisolone
Prognosis
jenkins-FCD Prod-411 e00897e83867fcfa48419861683711f8d99adb75